Fritextsökning
Innehållstyper
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Norden kapprustar i kampen om ESS
Danmark och Sverige går nu samman för att kunna matcha det spanska budet för byggnationen av forskningsstationen European Spallation Source.
-
Tre nya toppar i Biolamina
Utökar samarbetet med Vitrolife och stärker bolaget med tre nya förmågor.
-
Stockholm-Uppsala life science cluster in brief
Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.
-
Sverige snart klart för ESS
Under ett möte i Bryssel i går kväll uttalade majoriteten av de inblandade länderna sitt stöd för att forskningsanläggningen förläggs till Lund.
-
Söker nya behandlingsmål genom öppen innovation
Tio läkemedelsbolag har tillsammans med amerikanska forskningsfinansiärer ingått ett nytt samarbete baserat på öppen innovation.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Filter tips for safer pipetting and better accuracy
Biohit has launched new Safetyspace Filter Tips that have more space between the sample and the filter than conventional filter tips usually have.
-
Mingling do's and don'ts
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Genombrott för forskning om Alzheimer
Isländsk forskning stödjer teorin om att plack orsakar Alzheimers.
-
Northern Light Pharmaceuticals nära mål
Planen var att ta över tre av Astrazenecas forskningsprojekt. Men att hitta kapital var svårare än Northern Light Pharmaceuticals kunde tro.
-
Ökning för kliniska studier
Enligt siffror från Läkemedelsverket ser trenden för klinisk forskning ut att vända. För första gången på flera år stiger antalet kliniska studier i Sverige.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Swedish life science in political focus
It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Recipharm närmar sig börsen
Genomför nu nyemission på 900 miljoner kronor inför den kommande noteringen på Stockholmsbörsen.
BREAKING